Rishav Das
Vellore, TN 632014, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Emerging therapeutic strategies for triple-negative breast cancer using ruthenium, iridium, and rhenium complexes.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: August 20, 2026
Turning Off the Powerhouse: Mitochondria-Targeted DPPZ-Ru(II)/Ir(III)/Re(I) Complexes Trigger Dual Mitophagy and Apoptosis To Halt Triple-Negative Breast Cancer.
Journal: Journal of medicinal chemistry
Published: February 02, 2026
Turning the Spotlight Away from PDT: Chemodynamic Dominance of 2-(2-Bromopyridin-4-yl)-1H-imidazo[4,5-f][1,10]phenanthroline Based Ru(II)/Ir(III)/Re(I) Complexes against MDA-MB-231.
Journal: Journal of medicinal chemistry
Published: December 07, 2025
Dual functioning Ru(II)/Ir(III) complexes for ferroptosis and apoptosis in triple-negative breast cancer: a proof of concept by glutathione depletion.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: November 05, 2025
Butterfly-like photo-responsive cyclometalated Ir(III) complex: emergence of a future cancer therapeutic agent.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: September 16, 2025
Synthesis, characterization, biomolecular interaction, potent aqueous singlet oxygen generation and NADH photo-oxidation of phenanthroline-based cyclometalated Ir(iii) complexes.
Journal: RSC advances
Published: August 23, 2025
Rhodamine: Promising Theranostic Agent in Cancer Therapy.
Journal: Chemistry, an Asian journal
Published: June 10, 2025
The role of ancillary ligands on benzodipyridophenazine-based Ru(II)/Ir(III) complexes in dark and light toxicity against TNBC cells.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: February 25, 2025
Re(I)[2-aryl-1H-imidazo[4,5-f][1,10]phenanthroline] tricarbonyl chloride complexes for selective cancer therapy via a potential DNA damage mechanism.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: March 12, 2024
GSH resistant, luminescent 2-(pyren-1-yl)-1H-imidazo[4,5-f][1,10]phenanthroline-based Ru(II)/Ir(III)/Re(I) complexes for phototoxicity in triple-negative breast cancer cells.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: July 26, 2023
Different routes for the construction of biologically active diversely functionalized bicyclo[3.3.1]nonanes: an exploration of new perspectives for anticancer chemotherapeutics.
Journal: RSC advances
Published: March 27, 2023
Showing 1-11 of 11
Last Updated: 09/26/2026